Immunology of a transmissible cancer spreading among tasmanian devils

Journal of Immunology

Volumn 195, Issue 1, 2015, Pages 23-29

  Woods, Gregory M ^a,b   Howson, Lauren J ^a,d   Brown, Gabriella K ^a,e   Tovar, Cesar ^a   Kreiss, Alexandre ^a   Corcoran, Lynn M ^c   Lyons, A Bruce ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1;

ANTIGEN RECOGNITION; BITE; CANCER CELL; CANCER IMMUNOLOGY; CARNIVORE DISEASE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DEVIL FACIAL TUMOR DISEASE; DISEASE TRANSMISSION; FACE TUMOR; GENETIC VARIABILITY; IMMUNE RESPONSE; MARSUPIAL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TASMANIAN DEVIL; TUMOR ESCAPE; ANIMAL; AUSTRALIA; BITES AND STINGS; CARNIVORY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; FEMALE; GENETICS; IMMUNOLOGY; MALE; MORTALITY; NATURAL KILLER CELL; PATHOLOGY; SCHWANN CELL;

ANIMALS; BITES AND STINGS; CARNIVORY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DISEASE TRANSMISSION, INFECTIOUS; FACIAL NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; MALE; MARSUPIALIA; MORTALITY; SCHWANN CELLS; TASMANIA;

EID: 84932145933     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500131     Document Type: Review

References (64)

1. Welsh, J. S. 2011. Contagious cancer. Oncologist 16: 1-4.
2. Valenzano Menada, M., M. Moioli, A. Garaventa, P. Nozza, M. Foppiano, N. Trimarchi, and E. Fulcheri. 2010. Spontaneous regression of transplacental metastases from maternal melanoma in a newborn: case report and review of the literature. Melanoma Res. 20: 443-449.
3. Penn, I. 1978. Tumors arising in organ transplant recipients. Adv. Cancer Res. 28: 31-61.
4. Scanlon, E. F., R. A. Hawkins, W. W. Fox, and W. S. Smith. 1965. Fatal homotransplanted melanoma: a case report. Cancer 18: 782-789.
5. Murchison, E. P., O. B. Schulz-Trieglaff, Z. Ning, L. B. Alexandrov, M. J. Bauer, B. Fu, M. Hims, Z. Ding, S. Ivakhno, C. Stewart, et al. 2012. Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell 148: 780-791.
6. Murchison, E. P., C. Tovar, A. Hsu, H. S. Bender, P. Kheradpour, C. A. Rebbeck, D. Obendorf, C. Conlan, M. Bahlo, C. A. Blizzard, et al. 2010. The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science 327: 84-87.
7. Hawkins, C. E., C. Baars, H. Hesterman, G. J. Hocking, M. E. Jones, B. Lazenby, D. Mann, N. Mooney, D. Pemberton, S. Pyecroft, et al. 2006. Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrisii. Biol. Conserv. 131: 307-324.
8. Pyecroft, S. B., A. M. Pearse, R. Loh, K. Swift, K. Belov, N. Fox, E. Noonan, D. Hayes, A. Hyatt, L. Wang, et al. 2007. Towards a case definition for devil facial tumour disease: what is it? EcoHealth 4: 346-351.
9. Lachish, S., M. Jones, and H. McCallum. 2007. The impact of disease on the survival and population growth rate of the Tasmanian devil. J. Anim. Ecol. 76: 926-936.
10. Murchison, E. P., D. C. Wedge, L. B. Alexandrov, B. Fu, I. Martincorena, Z. Ning, J. M. Tubio, E. I. Werner, J. Allen, A. B. De Nardi, et al. 2014. Transmissible dog cancer genome reveals the origin and history of an ancient cell lineage. Science 343: 437-440.
11. Cohen, D. 1973. The biological behaviour of the transmissible venereal tumour in immunosuppressed dogs. Eur. J. Cancer 9: 253-258.
12. Murchison, E. P. 2008. Clonally transmissible cancers in dogs and Tasmanian devils. Oncogene 27(Suppl. 2): S19-S30.
13. Murgia, C., J. K. Pritchard, S. Y. Kim, A. Fassati, and R. A. Weiss. 2006. Clonal origin and evolution of a transmissible cancer. Cell 126: 477-487.
14. Strakova, A., and E. P. Murchison. 2014. The changing global distribution and prevalence of canine transmissible venereal tumour. BMC Vet. Res. 10: 168.
15. Siddle, H. V., and J. Kaufman. 2015. Immunology of naturally transmissible tumours. Immunology 144: 11-20.
16. Belov, K. 2012. Contagious cancer: lessons from the devil and the dog. BioEssays 34: 285-292.
17. Loh, R., J. Bergfeld, D. Hayes, A. O'hara, S. Pyecroft, S. Raidal, and R. Sharpe. 2006. The pathology of devil facial tumor disease (DFTD) in Tasmanian devils (Sarcophilus harrisii). Vet. Pathol. 43: 890-895.
18. Tovar, C., D. Obendorf, E. P. Murchison, A. T. Papenfuss, A. Kreiss, and G. M. Woods. 2011. Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies. Vet. Pathol. 48: 1195-1203.
19. Pearse, A. M., and K. Swift. 2006. Allograft theory: transmission of devil facialtumour disease. Nature 439: 549.
20. Miller, W., V. M. Hayes, A. Ratan, D. C. Petersen, N. E. Wittekindt, J. Miller, B. Walenz, J. Knight, J. Qi, F. Zhao, et al. 2011. Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil). Proc. Natl. Acad. Sci. USA 108: 12348-12353.
21. Siddle, H. V., A. Kreiss, M. D. Eldridge, E. Noonan, C. J. Clarke, S. Pyecroft, G. M. Woods, and K. Belov. 2007. Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial. Proc. Natl. Acad. Sci. USA 104: 16221-16226.
22. Pemberton, D., and D. Renouf. 1993. A field-study of communication and socialbehavior of the Tasmanian devil at feeding sites. Aust. J. Zool. 41: 507-526.
23. Hamede, R., S. Lachish, K. Belov, G. Woods, A. Kreiss, A. M. Pearse, B. Lazenby, M. Jones, and H. McCallum. 2012. Reduced effect of Tasmanian devil facial tumor disease at the disease front. Conserv. Biol. 26: 124-134.
24. Hamede, R., H. McCallum, and M. E. Jones. 2008. Seasonal, demographic and density-related patterns of contact between Tasmanian devils (Sarcophilus harrisii): implications for transmission of devil facial tumour disease. Austral Ecol. 33: 614-622.
25. Jurd, R. D. 1994. "Not proper mammals": immunity in monotremes and marsupials. Comp. Immunol. Microbiol. Infect. Dis. 17: 41-52.
26. Croix, D. A., N. K. Samples, J. L. Vandeberg, and W. H. Stone. 1989. Immune response of a marsupial (Monodelphis domestica) to sheep red blood cells. Dev. Comp. Immunol. 13: 73-78.
27. Montali, R. J., M. Bush, R. Cromie, S. M. Holland, J. N. Maslow, M. Worley, F. G. Witebsky, and T. M. Phillips. 1998. Primary Mycobacterium avium complex infections correlate with lowered cellular immune reactivity in Matschie's tree kangaroos (Dendrolagus matschiei). J. Infect. Dis. 178: 1719-1725.
28. Wilkinson, R., I. Kotlarski, M. Barton, and P. Phillips. 1992. Isolation of koala lymphoid cells and their in vitro responses to mitogens. Vet. Immunol. Immunopathol. 31: 21-33.
29. Fox, D. H., D. T. Rowlands, Jr., and D. B. Wilson. 1976. Proliferative reactivity of opossum peripheral blood leukocytes allogeneic cells, mitogens, and specific antigens. Transplantation 21: 164-168.
30. Stone, W. H., D. A. Brunn, E. B. Foster, G. S. Manis, E. S. Hoffman, D. G. Saphire, J. L. VandeBerg, and A. J. Infante. 1998. Absence of a significant mixed lymphocyte reaction in a marsupial (Monodelphis domestica). Lab. Anim. Sci. 48: 184-189.
31. Young, L. J., and E. M. Deane. 2007. Culture and stimulation of tammar wallaby lymphocytes. Vet. Res. Commun. 31: 685-701.
32. Kreiss, A., N. Fox, J. Bergfeld, S. J. Quinn, S. Pyecroft, and G. M. Woods. 2008. Assessment of cellular immune responses of healthy and diseased Tasmanian devils (Sarcophilus harrisii). Dev. Comp. Immunol. 32: 544-553.
33. Woods, G. M., A. Kreiss, K. Belov, H. V. Siddle, D. L. Obendorf, and H. K. Muller. 2007. The immune response of the Tasmanian devil (Sarcophilus harrisii) and devil facial tumour disease. EcoHealth 4: 338-345.
34. Kreiss, A., D. L. Obendorf, S. Hemsley, P. J. Canfield, and G. M. Woods. 2009. A histological and immunohistochemical analysis of lymphoid tissues of the Tasmanian devil. Anat. Rec. (Hoboken) 292: 611-620.
35. Howson, L. J., K. M. Morris, T. Kobayashi, C. Tovar, A. Kreiss, A. T. Papenfuss, L. Corcoran, K. Belov, and G. M. Woods. 2014. Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors. Anat. Rec. (Hoboken) 297: 925-938.
36. Kreiss, A., B.Wells, and G.M. Woods. 2009. The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells. Vet. Immunol. Immunopathol. 130: 135-137.
37. Brown, G. K., A. Kreiss, A. B. Lyons, and G. M. Woods. 2011. Natural killer cell mediated cytotoxic responses in the Tasmanian devil. PLoS ONE 6: e24475.
38. Jones, M. E., D. Paetkau, E. Geffen, and C. Moritz. 2004. Genetic diversity and population structure of Tasmanian devils, the largest marsupial carnivore. Mol. Ecol. 13: 2197-2209.
39. Jones, M. E., D. Paetkau, E. Geffen, and C. Moritz. 2003. Microsatellites for the Tasmanian devil (Sarcophilus laniarius). Mol. Ecol. Notes 3: 277-279.
40. Brüniche-Olsen, A., M. E. Jones, J. J. Austin, C. P. Burridge, and B. R. Holland. 2014. Extensive population decline in the Tasmanian devil predates European settlement and devil facial tumour disease. Biol. Lett. 10: 20140619.
41. O'Brien, S. J., M. E. Roelke, L. Marker, A. Newman, C. A. Winkler, D. Meltzer, L. Colly, J. F. Evermann, M. Bush, and D. E. Wildt. 1985. Genetic basis for species vulnerability in the cheetah. Science 227: 1428-1434.
42. Castro-Prieto, A., B. Wachter, and S. Sommer. 2011. Cheetah paradigm revisited: MHC diversity in the world's largest free-ranging population. Mol. Biol. Evol. 28: 1455-1468.
43. Kreiss, A., Y. Cheng, F. Kimble, B. Wells, S. Donovan, K. Belov, and G. M. Woods. 2011. Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity. PLoS ONE 6: e22402.
44. McDevitt, H. O. 2000. Discovering the role of the major histocompatibility complex in the immune response. Annu. Rev. Immunol. 18: 1-17.
45. Siddle, H. V., J. Marzec, Y. Cheng, M. Jones, and K. Belov. 2010. MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer. Proc. Biol. Sci. 277: 2001-2006.
46. Watanabe, T., Y. Oda, S. Tamiya, K. Masuda, and M. Tsuneyoshi. 2001. Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunoochemical analysis in the comparison between benign and malignant components. J. Clin. Pathol. 54: 631-636.
47. Morris, K., and K. Belov. 2013. Does the devil facial tumour produce immunosuppressive cytokines as an immune evasion strategy? Vet. Immunol. Immunopathol. 153: 159-164.
48. Gastl, G. A., J. S. Abrams, D. M. Nanus, R. Oosterkamp, J. Silver, F. Liu, M. Chen, A. P. Albino, and N. H. Bander. 1993. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55: 96-101.
49. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
50. Larmonier, N., M. Marron, Y. Zeng, J. Cantrell, A. Romanoski, M. Sepassi, S. Thompson, X. Chen, S. Andreansky, and E. Katsanis. 2007. Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-b and IL-10. Cancer Immunol. Immunother. 56: 48-59.
51. Harrison, G. A., and D. N. Wedlock. 2000. Marsupial cytokines. Structure, function and evolution. Dev. Comp. Immunol. 24: 473-484.
52. Assoian, R. K., A. Komoriya, C. A. Meyers, D. M. Miller, and M. B. Sporn. 1983. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258: 7155-7160.
53. Torres-Aguilar, H., S. R. Aguilar-Ruiz, G. González-Pérez, R. Munguía, S. Bajanã, M. A. Meraz-Ríos, and C. Sánchez-Torres. 2010. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J. Immunol. 184: 1765-1775.
54. Fassati, A., and N. A. Mitchison. 2010. Testing the theory of immune selection in cancers that break the rules of transplantation. Cancer Immunol. Immunother. 59: 643-651.
55. Esteller, M. 2006. Epigenetics provides a new generation of oncogenes and tumoursuppressor genes. Br. J. Cancer 94: 179-183.
56. Garcia-Lora, A., I. Algarra, and F. Garrido. 2003. MHC class I antigens, immune surveillance, and tumor immune escape. J. Cell. Physiol. 195: 346-355.
57. Lee, P. R., J. E. Cohen, and R. D. Fields. 2006. Immune system evasion by peripheral nerve sheath tumor. Neurosci. Lett. 397: 126-129.
58. Siddle, H. V., A. Kreiss, C. Tovar, C. K. Yuen, Y. Cheng, K. Belov, K. Swift, A. M. Pearse, R. Hamede, M. E. Jones, et al. 2013. Reversible epigenetic downregulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. Proc. Natl. Acad. Sci. USA 110: 5103-5108.
59. Su, A. I., T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101: 6062-6067.
60. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
61. Brown, G. K. 2013. Manipulating the immune response of Tasmanian devils to target devil facial tumour disease. Doctoral dissertation, University of Tasmania, Hobart, Tasmania, Australia.
62. Ljunggren, H. G., and K. Kärre. 1990. In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11: 237-244.
63. Pinfold, T. L., G. K. Brown, S. S. Bettiol, and G. M. Woods. 2014. Mouse model of Devil facial tumour disease establishes that an effective immune response can be generated against the cancer cells. Front. Immunol. 5: 251.
64. Kreiss, A., G. K. Brown, C. Tovar, A. B. Lyons, and G. M. Woods. 2015. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations. Vaccine 10.1016/j.vaccine.2015.01.039.